The virus-vector relationship of the tomato leafcurl virus (TLCV) and its vector,Bemisia tabaci gennadius (Hemiptera: aleyrodidae)

Basic studies carried out in India showed that the incubation period of TLCV in plants varied from 8 days in August to 90 days in winter. The acquisition threshold for the whitefly,Bemisia tabaci Gen., was 31 min; it resulted in 3% transmission. An acquisition access of 24 h for a female whitefly on a TLCV source resulted in 30% transmission. A minimum feeding period of 32 min was required by a viruliferous whitefly to cause infection on tomato test plants; this gave 4% transmission. With inoculation access of 24 h on tomato test plants, the transmission rose to 24%. Starving the vector for 1 h pre-acquisition or 1 h pre-inoculation resulted in higher levels of transmission of TLCV: 36 and 40%, respectively, compared with 20% for non-starved whiteflies. Extending the fasting period beyond 1 h resulted in a reduced transmission level. The whiteflies could acquire the virus from the cotyledonary leaves of an infected tomato plant, with a resultant 28% transmission; but infection did not occur when the whiteflies had an inoculation access to such leaves. Higher transmission rates were obtained when the younger leaves on tomato plants were used for acquisition and inoculation. Transmission was 8 and 38% when five whiteflies per plant were allowed 24 h of acquisition access to 11- and 2-month-old virus sources, respectively. After an acquisition access of 24 h to a TLCV source, male and female whiteflies retained their infectivity for 5 and 53 days, respectively. Nymphs can acquire and transmit the virus. When ten whiteflies of each sex were given 24 h of acquisition and of inoculation access, the subsequent transmission rate of males and females was 56 and 86%, respectively. This virus is not transovarially transmitted. Whitefly colonies raised on brinjal were more efficient (70 and 84% transmission in two experiments) than those raised on chilli, cotton, cowpea, tobacco or tomato.     

The use of vitamin D metabolites and analogues for the prevention of milk fever in dairy cattle

During the past decade it has been discovered that vitamin D₃ (cholecalciferol) is converted into 25-hydroxycholecalciferol in the liver and that this compound in converted in the kidney into 1, 25-dihydroxycholecalciferol. These metabolites and particularly 1, 25-dihydroxycholecalciferol, rather than vitamin D itself, have powerful effects on calcium metabolism, stimulating the absorption of calcium from the gastrointestinal tract and the resorption of calcium from bone. A synthetic analogue of these metabolites, 1-hydroxycholecalciferol, is rapidly converted in the liver into 1, 25-dihycroxycholecalciferol. Thus the two metabolites and the synthetic analogue may be valuable for the prevention on treatment of milk fever.The three compounds, when administered in doses ranging from 0.5 to 32g/kg bodyweight increase the concentrations of calcium and phosphorus in the blood plasma of cattle more quickly than much larger doses of vitamin D₃. Their principal effect is to stimulate the absorption of calcium from the gastrointestinal tract. At the same time they decrease the plasma concentration of magnesium slightly. Trials of 25-hydroxycholecalciferol and 1-hydroxycholecalciferol in the prevention of milk fever have shown promising results.

---

Kurzfassung Im vergangenen Jahrzehnt hat man festgestellt, dass das Vitamin D₃ (Cholecalciferol) in der Leber in 25-Hydroxycholecalciferol umgewandelt wird und die Nieren diese Verbindung wiederum in 1, 25-Dihydroxycholecalciferol umbilden. Mehr noch als Vitamin D selbst zeigen diese Metaboliten und hier insbesondere das 1, 25-Dihydroxychlecalciferol umfangreiche Auswirkungen auf den Kalziummetabolismus, indem sie die Kalziumabsorption aus dem Magen-Darmtrakt und die Kalziumresorption der Knochen anregen. Ein synthetischer Analogstoff zu diesen Metaboliten, das 1- Hydroxycholecalciferol, wird in der Leber rasch in 1, 25-Dihydroxycholecalciferol umgewandelt. Die beiden Metaboliten und der synthetische Analogwirkstoff könnten daher für die Milchfieberprophylaxe bzw-therapie von Nutzen sein.Werden die drei Verbindungen in Dosen von 0,5 bis 32g/kg Körpergewicht verabreicht, so erhöht sich die Kalzium-und Phosphorkonzentration im Blutplasma der Kühe schneller als bei bedeutend höheren Dosen von Vitamin D₃. Ihre Hauptwirkung liegt in der Anregung der Kalzium-absorption aus dem Magen-Darmtrakt. Gleichzeitig bauen sie jedoch auch in geringfügigem masse die Magnesiumkonzentration im Plasma ab. Versuche mit 25-Hydroxycholecalciferol und 1-Hydroxycholecalciferol haben bei der Milchfieberprophylaxe vielversprechende Ergebnisse gezeigt.

---

Resume Au cours de la dernière décennie, on a découvert que la vitamine D₃ (cholécalciférol) se transformait en 25-hydroxycholécalciférol dans le foie et que ce composé se transformait en 1, 25-dihydroxy-cholécalciférol dans le rein. Ces métabolites, et en particulier le 1, 25-dihydroxycholécalciférol, ont, plus que la vitamine D elle-même, des effets puissants sur le métabolisme du calcium: ils stimulent l'absorption du calcium de l'appareil gastrointestinal et la résorption du calcium des os. Une substance homologue synthétique de cés metabolites, le 1-hydroxycholécalciférol, se transforme rapidement en 1, 25-dihydroxycholécalciférol dans le foie. Les deux métabolites et la substance homologue synthétique peuvent donc s'avérer précieux dans la prévention ou le traitement de la fièvre laiteuse.Administrés en doses allant de 0,5 à 32g/kg de poids corporel, ces trois composés augmentent les concentrations de calcium et de phosphore dans le plasma sanguin du bétail plus rapidement que des doses beaucoup plus fortes de vitamine D₃. Ils ont pour principal effet de stimuler l'absorption du calcium de l'appareil gastro-intestinal. Simultanément, ils réduisent légèrement la concentration de magnésium dans le plasma. Les essais d'utilisation du 25-hydroxycholécalciférol et du 1-hydroxycholécalciférol pour la prévention de la fièvre laiteuse ont donné des résultats prometteurs.

---

Riassunto Nel corso dell'ultimo decennio si è scoperto che la vitamina D₃ (colecalciferolo) viene trasformata nel fegato in 25-idrossicolecalciferolo, il quale, a sua volta, si trasforma nel rene in 1, 25-diidrossicolecalciferolo. Detti metaboliti, ed in specie l'1, 25-diidrossicolecalciferolo., più che la stessa vitamina D, hanno potenti effetti sul metabolismo del calcio, poichè ne stimolano l'assorbimento da parte dell' apparato digerente e l'anabolizzazione da parte delle ossa. Un composto sintetico analogo di questi metobiliti, l'1, idrossicolecalciferolo, viene rapidamente trasformato nel fegato in 1, 25-diidrossicolecalciferolo. Perciò i due metaboliti e il composto sintetico analogo possono essere utili per la profilassi e la cura della febbre da latte.I tre composti, se somministrati in dosi da 0.5 a 32g/kg peso corporeo, aumentano la concentrazione del calcio e del fosforo nel plasma sanguigno del bestiame più rapidamente di dosi molto maggiori di vitamina D₃. Il loro effetto principale è quello di stimolare l'assorbimento del calcio da parte dell'apparato digerente. Contemporaneamente, essi riducono leggermente la concentrazione di magnesio nel plasma. Esperimenti con il 25-idrossicolecalciferolo nella profilassi della febbre da latte hanno dato risultati promettenti.

     

Synchronization of oestrus with prostaglandins

Luteolytic doses of the Tham salt of PGF₂ or one of its synthetic analogues cause premature regression of, the corpus luteum between the 5th and the 16th day of the oestrous cycle, inducing, 2 to 4 days after the injection, endcrine changes similar to a normal lultolysis and oestrus. After insemination at the time of this oestrus or at predefined times 72 to 96 hours after the injection, fertility is similar to that in controls. The paractical use of prostaglandins for the synchronization of oestrus in a herd of randomly cyclic animals takes account of the fact that only animals between the 5th and the 16th day respond to an injection. Various techniques are proposed, notably a double injection with an interval of 10–12 days.

---

Kurzfassung Luteolytische Dosen eines Tham'schen Salzes von PGF₂, oder einer dessen synthetischen Analogen bringen vorzeitige Regressionen des corporis lutei zwischen dem 5ten und dem 16ten Tage hervor. Als Folge dieser Regressionen entwickeln sich innerhalb 2 bis 4 Tage nach der Einspritzung endokrine Veränderungen, die der normalen Luteolyse und Brunst ähnlich sind. Nach einer Besamung zur Zeit dieser Brunst oder zu vorherbestimmten Zeiten und zwar 72 und 92 Stunden nach der Einspritzung wird die gleiche Frunchtbarkeit wie in unbehandelten Kontrollen beobachtet. Nur ein Teil einer zyklischen Herde reagiert auf Prostaglandin, und es werden daher verschiedene Methoden der Viehwirtschaftsführung zur Überwindung dieses Problems erörtert, wie auch den Gebrauch einer Doppeleinspritzung von Prostaglandin mit einem 10 bis 12 tägigen Abstand zwischen den Behandlungen.

---

Resume Les doses lutéolytiques de sel Tham de PGF₂ ou d'un de ses analogues synthetiques causent une reégression prématurée du corps jaunne entre le 5ème et le 16ème jour du cycle provoquant, 2 à 4 jours après l'injections, des changements endocriniens semblales à une lutéolyse normale et à un oestrus. Après l'insémination au moment de cet oestrus ou à des temps prédéfinis de 72 à 96 heures après l'injection, la fertilité est semblable à celle des animaux témoins non traités. L'utilisation pratique des prostaß-landinesd pour la synchronisation des chaleurs dans un troupoeau de femelles cyclées tient compte du fait que seules les femelles entre le 5ème et 16ème jour du cycle répondent à une injection. Différentes techniques sont proposées, notamment la double injection à 10–12 jours d'intervalle.

---

Riassunto Le dosi luteolitiche del sale Them PGF₂ o di uno dei suoi analoghi sintetioi causano una regressione prematura del corpo giallo tra il 5^o ed il 16^o giorno del ciclo provooando, dopo un periodo che va dai 2 ai 4 giorni dall'iniezione, dei cambiamenti endocrini simili ad una luteolisi normale o ad un estro. Dopo l'inseminazine, nel momento di questo estro oppure in tempi predeterminati, in un periodo compreso tra 72 e 96 ore dopo l'iniezione, la fertilità è simile a quella jdegli animali di controllo non trattati. L'utilizzazione poratioa della prostaglandine per la sincronizzazione dei oalori in una mandria di femmine cicliche dimostra che le femmine rispondono all'iniezione soltanto tra il 5^o ed 16^o giorno del ciclo. Si propongono diverse techniche, in poarticolasre la doppia iniezione ad un intervallo di 10–12 giorni.

     

Intussusception following renal transplantation in dogs (author's transl)]

In a consecutive and non-selected study of 54 kidney transplanted dogs, 12 cases of intussusception of the small intestine developed in 8 dogs. The patogenesis is still unknown. It has been postulated that the time of the operation (4--7 hours) and the segmental termination of the post-operative atony in the intestine are essential factors in this fatal complication. The last 16 dogs in this material were peroperatively treated with antikolinergics (Mestinon NFN), which was continued until normal function of the intestine. In these dogs there were no evidence of intussusception. The value of this profylaxis is open to discussion and it is essential to solve the problem of intussusception through a "blind" and controlled trial.     

Variation of canine and feline frontal-plane QRS axes with lead choice and augmentation ratio

The intraindividual variability in mean electric axis referable to choice of ECG leads and augmentation ratio was investigated by means of a digital computer program. Although, in theory, the choice of leads for determining the QRS axis should make no difference, the maximum intraindividual variation in axis angle was about 50 degrees for canine and feline subjects. The angle conputed for the lead combinations I and III and I and aVF will usually fall within 5 to 10 degrees of the mean of all lead combinations, but larger variations are seen at time. The application of an "augmentation ratio" for the augmented unipolar leads was most helpful when it was individually computed. Further methods of lead-vector improvement are discussed.     

Alternative complement pathway in bovine serum: lysis of human erythrocytes.

The hemolysis of unsensitized human erythrocytes by fresh bovine serums was investigated. Lysis occurred in ethylene glycol bis-amino tetraacetate buffers and with serums depleted of Clq. Serums extensively absorbed with packed human erythrocytes at 0 C effectively lysed human erythrocytes, but optimal lytic capacity required target cells "sensitized" with a heat-stable serum factor. Lysis did not occur with serums absorbed with zymosan at 17 C or heat inactivated at 50 C. These results indicate that human erythrocytes can activate the alternative pathway of complement in bovine serums. Lysis can proceed in the apparent absence of antibodies, although their presence may enhance the reaction.